Primary Record
Revefenacin
Note: Only for scientific research or as raw materials for production.
- In stock
- 1,660 g
- Purity
- 98.4 %
- CAS
- 864750-70-9
Compound Identifiers & Properties
- CAS
- 864750-70-9
- PubChem CID
- 11753673
- SMILES
- CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N
- Canonical SMILES
- CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1
Names & Synonyms
- Revefenacin
- Yupelri
- revefenacina
- revefenacine
- 864750-70-9
- revefenacinum
- TD-4208
- Revefenacin [INN]
- Yupelri (TN)
- Revefenacin [WHO-DD]
- G2AE2VE07O
- Revefenacin (Standard)
- RefChem:57759
- REVEFENACIN [MI]
- GSK-1160724
- Revefenacin (USAN/INN)
- Revefenacin [USAN:INN]
- REVEFENACIN [USAN]
- UNII-G2AE2VE07O
- GSK1160724
- Revefenacin;GSK1160724
- SCHEMBL356480
- DTXSID701027775
- orb1299860
- CHEMBL3833319
- GTPL10129
- 864750-70-9 (free base)
- R03BB08
- REVEFENACIN [ORANGE BOOK]
- MFCD28386316
- C35H43N5O4
- DTXCID801513351
- GLXC-23321
- HMS3886K17
- HMS5084F21
- Revefenacin [USAN:INN:WHO-DD]
- AMY16789
- BCP15793
- EX-A1722
- EBC-27368
- HY-15851R
- s5258
- TD4208
- AKOS037649398
- ACN-051241
- CCG-270187
- CS-7743
- DB11855
- SB17262
- CID11753673
- GSK 1160724
- BS-18189
- CID 11753673
- CID:11753673
- DA-57407
- FR178690
- HY-15851
- SY235747
- TD-4208?
- SID:442882597
- NS00073361
- Revefenacin; TD-4208; GSK-1160724
- 1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
- A15986
- D10978
- A903445
- C583570
- EN300-20352165
- 1-(2-(4-((4-Carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl N-((1,1'-biphenyl)-2-yl)carbamate
- Q27278649
- 1-(2-(4-((4-Carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
- B0084-470939
- [1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate
- Biphenyl-2-ylcarbamic acid, 1-(2-((4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl)methylamino)ethyl)piperidin-4-yl ester
- Biphenyl-2-ylcarbamic acid 1-(2-((4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl)methylamino)ethyl)piperidin-4-yl ester
- Carbamic acid, N-(1,1'-biphenyl)-2-yl-, 1-(2-((4-((4-(aminocarbonyl)-1-piperidinyl)methyl)benzoyl)methylamino)ethyl)-4-piperidinyl ester
- TD-4208; GSK-1160724;[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate
- Revefenacin; TD 4208; TD4208; GSK-1160724; GSK1160724; GSK 1160724
- (1-(2-((4-((4-carbamoylpiperidin-1-yl)methyl)benzoyl)-methylamino)ethyl)piperidin-4-yl) N-(2-phenylphenyl)carbamate
- [1-[2-[[4-[(4-carbamoyl-1-piperidyl)methyl]benzoyl]-methyl-amino]ethyl]-4-piperidyl] N-(2-phenylphenyl)carbamate
- 1-(2-((4-((4-(Aminocarbonyl)-1-piperidinyl)methyl)benzoyl)methylamino)ethyl)-4-piperidinyl N-(1,1'-biphenyl)-2-ylcarbamate
- 1-(2-(1-(4-((4-carbamoylpiperidin-1-yl)methyl)phenyl)-N-methylformamido)ethyl)piperidin-4-yl N-((1,1'-biphenyl)-2-yl)carbamate
- 1-[2-(1-{4-[(4-carbamoylpiperidin-1-yl)methyl]phenyl}-N-methylformamido)ethyl]piperidin-4-yl N-{[1,1'-biphenyl]-2-yl}carbamate
- 1-[2-[[4-[[4-(Aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl N-[1,1 inverted exclamation marka-biphenyl]-2-ylcarbamate
- 1-[2-[4-[(4-Carbamoyl-1-piperidinyl)methyl]-N-methylbenzamido]ethyl]-4-piperidinyl 2-Biphenylylcarbamate
- 1211931-83-7
- Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl ester; Carbamic acid, [1,1'-biphenyl]-2-yl-, 1-[2-[[4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-
- TD-4208;1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1-biphenyl]-2-ylcarbamate